Navigation Links
Vermillion Reports Results for Third Quarter 2011
Date:11/9/2011

AUSTIN, Texas, Nov. 9, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, reported financial results for the third quarter ended September 30, 2011.

Q3 2011 Highlights

  • Performed an estimated 4,108 OVA1® tests during the third quarter, up 5% from the previous quarter.
  • In October, released positive top-line data from intended use clinical study of the company's peripheral artery disease (PAD) blood test. Developed a biomarker panel which identifies more than 80% of PAD patients who are missed by the Framingham Risk Score.
  • In November, strengthened patent portfolio with notice of allowance received for key PAD biomarker patent, as well as issued a patent for lung cancer biomarker.
  • Enhanced management team with addition of Donald Munroe, Ph.D. as chief scientific officer and vice president of research and development.
  • Presented data at the European Society of Gynecologic Oncology meeting in Milan, highlighting the improvement in sensitivity when using imaging in conjunction with OVA1 to evaluate adnexal masses for disease.
  • Entered into an asset purchase agreement with Correlogic Systems, Inc., whereby Vermillion has agreed to pay $435,000 in cash for substantially all of Correlogic's assets in connection with its ovarian cancer diagnostics business, which include certain diagnostic samples, software and IP.  Correlogic is in Chapter 11 proceedings in the United States Bankruptcy Court for the District of Maryland and the transaction is subject to Court approval.

  • Q3 2011 Financial HighlightsRevenue for the third quarter of 2011 included $206,000 from sales of OVA1, as compared to $114,000 in the same year-ago quarter. Total revenue for the third quarter of 2011 was $320,000 versus $413,000 in the same year-ago quarter. License revenue for the third quar
    '/>"/>

    SOURCE Vermillion, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Vermillion to Present at Stephens Fall Investment Conference on November 16, 2011
    2. Vermillion Engages Liolios Group to Lead Investor Relations Program
    3. Vermillion Enhances Management Team With A Key Addition
    4. Vermillion Appoints Distribution Partner for OVA1® in Israel and the Palestine Territories
    5. Vermillion Reports Financial Results for the First Quarter 2011
    6. Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test
    7. Vermillion Attends 42nd Annual Meeting of the Society of Gynecologic Oncologists
    8. Vermillion to Present at the Roth 23rd Annual OC Growth Stock Conference March 13-16, 2011, Laguna Niguel, CA
    9. Vermillion Announces $21.8 Million Public Offering
    10. Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Fourth Quarter 2010
    11. Vermillion Announces Issuance of Patent for Peripheral Artery Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
    (Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
    (Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
    Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
    ... Champions Biotechnology, Inc. (OTC ... with a predictive preclinical platform aimed at accelerating ... drugs, has established an exclusive licensing agreement with ... University,s wholly owned technology transfer company. The licensing ...
    ... Bellicum Pharmaceuticals, Inc. today announced $4.5 million in Series ... used to complete the company,s ongoing Phase I/IIa trial of ... to prepare for Phase IIb trials. The company anticipates reporting ... , The new funding brings the total raised to date ...
    Cached Medicine Technology:Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer 2Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer 3Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer 4Bellicum Pharmaceuticals Announces $4.5 Million in New Funding 2
    (Date:4/17/2014)... uncommon these days to find a colored ribbon representing a ... cancer. But what color ribbon does one think of with ... color, for many suffering from the disease, black may be ... study consisting of lung cancer patients, primarily smokers between the ... light on the stigma often felt by these patients, the ...
    (Date:4/17/2014)... improves general blood flow and alleviates muscle soreness ... at the University of Illinois at Chicago. , ... in the Archives of Physical Medicine and ... function in people who had not exercised, suggesting ... their level of physical activity. , Improved circulation ...
    (Date:4/17/2014)... found that India,s shocking rates of suicide are highest ... clinging to tiny smallholdings less than one hectare ... cotton and coffee, that are highly susceptible to global ... previous case studies that point to a crisis in ... of the nation,s economy during the 90s. Researchers say ...
    (Date:4/17/2014)... April 17, 2014 Giving patients adrenaline after they suffer ... increase their prospects of surviving long-term, according to new ... number of patients who have a cardiac arrest get ... cardiac arrest for decades," said Dr. Steve Lin, an ... "Yet, despite advances in medical treatment, long-term survival rates ...
    (Date:4/17/2014)... lost its status as the leading weapon against the ... life, with new research indicating it simply needs to ... use of the cheap anti-malarial drug chloroquine in treating ... of more than half a million people each year ... has developed resistance to chloroquine, but research carried out ...
    Breaking Medicine News(10 mins):Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Massage therapy improves circulation, eases muscle soreness 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:Scientists find new way to fight malaria drug resistance 2
    ... published this week in the New England Journal of ... patients with a specific genetic mutation benefit from the drug ... 15.9 months. In patients who responded, the drug stopped cancer ... with a BRAF V600 mutation, this drug is a breakthrough. ...
    ... emerging field of systems biology, UT Southwestern Medical Center researchers ... cell,s sense of direction and then confirmed those predictions in ... explain how mammalian cells establish the sense of direction necessary ... form of E. coli bacteria employ to hijack ...
    ... Mo. Many leading causes of death are ... activity. Adults in minority populations have lower levels ... deaths, according to the Department of Health & ... Missouri researchers found that minority adults who received ...
    ... By Steven Reinberg HealthDay Reporter , ... on Wednesday blocked implementation of an FDA mandate that ... images on packages of cigarettes. The proposed requirement ... set to kick in this September, would have emblazoned ...
    ... All children can benefit from going to preschool, especially those ... where parents don,t provide much mental stimulation, a new study ... from 600 families who were followed from age 2 until ... went to preschool did better once they started kindergarten than ...
    ... refuting a hypothesis can be as significant as proving ... elucidating how diseases proceed with a view toward preventing, ... scientists from spending precious years of effort exploring a ... Proceedings of the National Academy of Sciences , Munich-based ...
    Cached Medicine News:Health News:Investigators predict, confirm how E. coli bacteria hijack cells' directional mechanism 2Health News:Fitness programs for minority adults lack cultural relevance, MU study finds 2Health News:Judge Blocks Plan for Graphic Cigarette Warnings 2Health News:Preschool Kids Best Prepared for Kindergarten: Study 2Health News:Observations refute widely held view on causal mechanism in ALS 2Health News:Observations refute widely held view on causal mechanism in ALS 3
    Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
    ... Mo Bio Vortex Adapter in conjunction with the ... Using the Mo Bio Vortex Adapter is ... Fast Prep machines which offer the same technology. ... centrifuge tubes at one time and will fit ...
    ... Combines BchiVac V-500 with Vacuum Controller ... controls vacuum levels from Compact Housing ... membrane vacuum pump designed to handle most vacuum ... use with up to two rotary evaporators ...
    ... V-500 with Vacuum Controller V-800 and water-cooled secondary ... Model V-500 is a powerful ... vacuum applications. Applications Ideally suited ... Laboratory vacuum source for instruments including ...
    Medicine Products: